Whitehouse D B, Tomkins J, Lovegrove J U, Hopkinson D A, McMillan W O
MRC Human Biochemical Genetics Unit, Galton Laboratory, Department of Biology, University College London, U.K.
Mol Biol Evol. 1998 Apr;15(4):456-62. doi: 10.1093/oxfordjournals.molbev.a025942.
The expanding molecular database provides unparalleled opportunities for characterizing genes and for studying groups of related genes. We use sequences drawn from the database to construct an evolutionary framework for examining the important glycolytic enzyme phosphoglucomutase (PGM). Phosphoglucomutase plays a pivotal role in the synthesis and utilization of glycogen and is present in all organisms. In humans, there are three well-described isozymes, PGMI, PGM2, and PGM3. PGM1 was cloned 5 years ago; however, repeated attempts using both immunological approaches and molecular probes designed from PGM1 have failed to isolate either PGM2 or PGM3. Using a phylogenetic strategy, we first identified 47 highly divergent prokaryotic and eukaryotic PGM-like sequences from the database. Although overall amino acid identity often fell below 20%, the relative order, position, and sequence of three structural motifs, the active site and the magnesium--and sugar-binding sites, were conserved in all 47 sequences. The phylogenetic history of these sequences was complex and marked by duplications and translocations; two instances of transkingdom horizontal gene transfer were identified. Nonetheless, the sequences fell within six well-defined evolutionary lineages, three of which contained only prokaryotes. Of the two prokaryotic/eukaryotic lineages, one contained bacterial, yeast, slimemold, invertebrate, and vertebrate homologs to human PGM1 and the second contained likely homologs to human PGM2. Indeed, an amino acid sequence, derived from a partial human cDNA, that fell within the second cross-kingdom lineage bears several characteristics expected for PGM2. A third lineage may contain homologs to human PGM3. On a general level, our phylogenetic-based approach shows promise for the further utilization of the extensive molecular database.
不断扩展的分子数据库为基因特征描述和相关基因群组研究提供了无与伦比的机会。我们利用从数据库中提取的序列构建了一个进化框架,用于研究重要的糖酵解酶磷酸葡萄糖变位酶(PGM)。磷酸葡萄糖变位酶在糖原的合成和利用中起关键作用,存在于所有生物体中。在人类中,有三种已被充分描述的同工酶,即PGM1、PGM2和PGM3。PGM1于5年前被克隆;然而,使用免疫方法和基于PGM1设计的分子探针进行的多次尝试都未能分离出PGM2或PGM3。我们采用系统发育策略,首先从数据库中鉴定出47个高度分化的原核和真核PGM样序列。尽管总体氨基酸同一性常常低于20%,但在所有47个序列中,三个结构基序(活性位点以及镁离子和糖结合位点)的相对顺序、位置和序列都是保守的。这些序列的系统发育历史很复杂,以重复和易位为特征;鉴定出了两例跨界水平基因转移。尽管如此,这些序列可分为六个明确的进化谱系,其中三个仅包含原核生物。在两个原核生物/真核生物谱系中,一个包含与人类PGM1同源的细菌、酵母、黏菌、无脊椎动物和脊椎动物序列,另一个包含可能与人类PGM2同源的序列。实际上,源自人类部分cDNA的一个氨基酸序列,落在第二个跨界谱系内,具有PGM2预期的几个特征。第三个谱系可能包含与人类PGM3同源的序列。总体而言,我们基于系统发育的方法显示出进一步利用广泛分子数据库的前景。